The aim of this study was to evaluate the contribution of plasmid-mediated genes and efflux to fluoroquinolone resistance in collection of Achromobacter spp. gathered during a 3-year period. Susceptibility to ciprofloxacin and levofloxacin was tested by disk diffusion and microdilution tests for a collection of 98 Achromobacter spp. clinical isolates. Identification of fluoroquinolone-resistant isolates was performed by sequencing and phylogenetic analyses of the nrdA gene. Genetic relatedness among resistant isolates was determined by pulsed-field gel electrophoresis (PFGE) analysis. The influence of an H+ conductor cyanide m-chlorophenyl hydrazone (CCCP) and a resistance-nodulation-division-type efflux pump inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) on minimal inhibitory concentration (MIC) value was evaluated by broth microdilution. The presence of the plasmid-mediated qnrA, qnrB, qnrC, qnrS, and aac-(6')-Ib-cr genes was investigated by PCR and sequencing. Achromobacter spp. isolates that were resistant or intermediately resistant to fluoroquinolones in disk diffusion tests (44/98) were subjected to microdilution. As a result, 20/98 isolates were confirmed to be resistant to ciprofloxacin while 10/98 was resistant to levofloxacin. CCCP decreased twofold MIC value for ciprofloxacin in six isolates and more than 16 times in one isolate, while MIC value for levofloxacin was decreased in all isolates (twofold to more than eightfold). Fluoroquinolone-resistant isolates were identified as A. xylosoxidans with the nrdA gene sequencing. PFGE revealed that resistant isolates belonged to seven different genotypes. Ten isolates belonging to four genotypes were positive for the aac-(6')-Ib-cr gene. Although resistance to fluoroquinolones was not widespread among analyzed isolates, detected contribution of efflux pumps and the presence of the aac-(6')-Ib-cr gene present a platform for emergence of more resistant strains.

Department of Clinical Microbiology Mother and Child Health Care Institute of Serbia Dr Vukan Čupić Radoja Dakića 8 Belgrade 11070 Serbia

Faculty of Biology University of Belgrade Studentski trg 16 Belgrade 11000 Serbia

Faculty of Pharmacy University of Belgrade Vojvode Stepe 450 Belgrade 11221 Serbia

Institute of Molecular Genetics and Genetic Engineering University of Belgrade Vojvode Stepe 444a P O Box 23 Belgrade 11010 Serbia

Zobrazit více v PubMed

Antimicrob Agents Chemother. 2001 Jan;45(1):105-16 PubMed

Eur J Clin Microbiol Infect Dis. 2003 Jun;22(6):360-3 PubMed

J Antimicrob Chemother. 2005 Jul;56(1):20-51 PubMed

J Clin Microbiol. 2005 Jun;43(6):2998-3002 PubMed

Mem Inst Oswaldo Cruz. 2005 Oct;100(6):571-7 PubMed

Nat Med. 2006 Jan;12(1):83-8 PubMed

Antimicrob Agents Chemother. 2006 Nov;50(11):3953-5 PubMed

Can J Microbiol. 2006 Nov;52(11):1110-20 PubMed

J Antimicrob Chemother. 2007 Aug;60(2):394-7 PubMed

Antimicrob Agents Chemother. 2009 Jan;53(1):335-6 PubMed

Antimicrob Agents Chemother. 2009 Feb;53(2):639-45 PubMed

Eur J Clin Microbiol Infect Dis. 2011 Aug;30(8):973-80 PubMed

Antimicrob Agents Chemother. 2011 Oct;55(10):4912-4 PubMed

J Clin Microbiol. 2012 Sep;50(9):3010-5 PubMed

Curr Microbiol. 2012 Dec;65(6):673-8 PubMed

Antimicrob Agents Chemother. 2013 Jan;57(1):603-5 PubMed

Braz J Infect Dis. 2013 Jul-Aug;17(4):450-4 PubMed

Appl Environ Microbiol. 2013 Dec;79(23):7142-9 PubMed

Mol Biol Evol. 2013 Dec;30(12):2725-9 PubMed

Scand J Infect Dis. 2014 Feb;46(2):130-5 PubMed

Br J Haematol. 2014 Mar;164(6):804-10 PubMed

Trends Microbiol. 2014 Aug;22(8):438-45 PubMed

Antimicrob Agents Chemother. 2015 Feb;59(2):1152-61 PubMed

Microbiol Spectr. 2014 Oct;2(5):null PubMed

New Microbes New Infect. 2015 Dec 12;10:1-5 PubMed

Cornea. 2016 May;35(5):626-30 PubMed

Front Cell Infect Microbiol. 2017 May 29;7:224 PubMed

J Clin Microbiol. 1995 Sep;33(9):2233-9 PubMed

Antimicrob Agents Chemother. 1998 Jul;42(7):1778-82 PubMed